-
1
-
2
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
Published 2021-06-01“…Materials and Methods: Patients were enrolled from seven AINO (Italian Association of Neuro-Oncology) Institutions. The major inclusion criteria were: histologically confirmed diagnosis of glioblastoma, EGFR-amplified, one or more prior systemic therapies and ECOG PS ≤ 2. …”
Get full text
Article -
3
Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents
Published 2020-11-01Subjects: Get full text
Article -
4
-
5
Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects
Published 2022-03-01Get full text
Article -
6
-
7
Management of Brain and Leptomeningeal Metastases from Breast Cancer
Published 2020-11-01Get full text
Article -
8
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
Published 2023-06-01Get full text
Article -
9
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Published 2022-04-01Get full text
Article -
10
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
Published 2021-11-01Get full text
Article -
11
-
12
Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches
Published 2021-06-01Get full text
Article -
13
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma
Published 2022-08-01Get full text
Article -
14
-
15
-
16
-
17
Suicidality in Patients with Brain Tumors: A Brief Literature Review with Clinical Exemplar
Published 2020-12-01Get full text
Article -
18
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
Published 2024-01-01Get full text
Article